Zobrazeno 1 - 10
of 41
pro vyhledávání: '"J. Lee Villano"'
Autor:
Linda R. Bressler, Katie E. Long, J. Lee Villano, Nathalie Letarte, Michael Gabay, Joan M. Stachnik
Publikováno v:
Journal of Neuro-Oncology. 120:111-115
The EORTC-NCIC regimen for glioblastoma requires different dosing of temozolomide (TMZ) during radiation and maintenance therapy. This complexity is exacerbated by the availability of multiple TMZ capsule strengths. TMZ is an alkylating agent and the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6ce4aa156e260ab99a9088b9a0fd16bd
https://doi.org/10.1007/s11060-014-1523-1
https://doi.org/10.1007/s11060-014-1523-1
Autor:
Myrna R. Rosenfeld, Patrick Y. Wen, Eudocia Q. Lee, David A. Reardon, Lakshmi Nayak, J. Lee Villano
Publikováno v:
Journal of Neuro-Oncology. 113:143-147
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83aa36b8a6db72d30c84202fd3f61bed
https://doi.org/10.1007/s11060-013-1100-z
https://doi.org/10.1007/s11060-013-1100-z
Publikováno v:
Cancer Chemotherapy and Pharmacology. 70:1-15
Leptomeningeal carcinomatosis is a devastating complication of cancer and is likely increasing in incidence. The combination of widespread neuro-axial spread based on CSF flow and the blood-brain barrier (BBB) has favored immediate local delivery of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::87b5034ae46336de91476dc96026c628
https://doi.org/10.1007/s00280-012-1893-z
https://doi.org/10.1007/s00280-012-1893-z
Publikováno v:
The Oncologist. 16:1604-1613
Learning Objectives After completing this course, the reader will be able to: Evaluate patients with grade II and III meningiomas for possible implementation of adjuvant radiation therapy.Describe options of systemic treatment of refractory meningiom
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6876b7f74f9981a32379666ae3c837b3
https://doi.org/10.1634/theoncologist.2011-0193
https://doi.org/10.1634/theoncologist.2011-0193
Autor:
Manali Barua, Fred G. Barker, Herbert B. Newton, Herbert H. Engelhard, J. Lee Villano, Andrew K. Stewart, Kimberly R. Porter
Publikováno v:
Journal of Neurosurgery: Spine. 13:67-77
ObjectPatients having a primary tumor of the spinal cord, spinal meninges or cauda equina, are relatively rare. Neurosurgeons encounter and treat such patients, and need to be aware of their clinical presentation, tumor types, treatment options, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::81c4f39755d9b84d101d727a9befe4f4
https://doi.org/10.3171/2010.3.spine09430
https://doi.org/10.3171/2010.3.spine09430
Publikováno v:
Annals of Pharmacotherapy. 43:235-241
Background: Serum creatinine (SCr)-based formulas are used to estimate glomerular filtration rate (GFR) when calculating a dosage for carboplatin using the Calvert equation, but these formulas often underestimate measured GFR. The Modified Diet in Re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63c1c771601c33dfe384ece6e5a76751
https://doi.org/10.1345/aph.1l446
https://doi.org/10.1345/aph.1l446
Publikováno v:
Journal of Clinical Neuroscience. 21:121-123
Six months of maintenance temozolomide (TMZ) following concurrent TMZ chemotherapy and radiation therapy has become the standard of care in the treatment of glioblastoma. In addition, TMZ has also been used to treat other forms of glioma although les
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac642bbb475c17a21c6424e744593646
https://doi.org/10.1016/j.jocn.2013.03.039
https://doi.org/10.1016/j.jocn.2013.03.039
Publikováno v:
Cancer Chemotherapy and Pharmacology. 69:1113-1115
The benefit of six cycles of adjuvant temozolomide was documented in a randomized phase III (EORTC-NCIC CE.3) trial, and this therapy, following combined temozolomide and radiation, is the standard of care for patients with newly diagnosed glioblasto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fff79ca0454298986f64b50e5a25f3c
https://doi.org/10.1007/s00280-011-1796-4
https://doi.org/10.1007/s00280-011-1796-4
Autor:
Thomas Pittman, J. Lee Villano
Publikováno v:
Neuro-oncology. 16(8)
Historically, advances in oncologic therapy have been sequential. Changes in treatment have been the result of successive studies, each building on the results of those previously performed. This can be illustrated by Einhorn's studies in gonadal ger
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::122bfb4719c3cd1208c1d42a822ba9f5
https://pubmed.ncbi.nlm.nih.gov/24944226
https://pubmed.ncbi.nlm.nih.gov/24944226
Autor:
Faith G. Davis, Chris Normandeau, Valentina Moirangthem, Eric B. Durbin, J. Lee Villano, Jigisha P. Thakkar
Publikováno v:
Neuro-oncology. 17(1)
Metastases are the most common tumors of the central nervous system (CNS), with an incidence of approximately 7–14 persons per 100 000 population.1,2 The anatomical specialization of the blood-brain barrier allows the brain and CNS to harbor metast
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6b7a779f09fb91463b6abb1647bb206
https://pubmed.ncbi.nlm.nih.gov/24891450
https://pubmed.ncbi.nlm.nih.gov/24891450